Showing 1 - 20 results of 22 for search 'Thomas Burmeister', query time: 0.07s
Refine Results
-
1
-
2
Mutation-Guided Therapy for CML Blast Crisis: A Case Report by Benjamin N. Ostendorf, Hendrik Nogai, Claudia D. Baldus, Thomas Burmeister, Renate Arnold
Published 2015-01-01
Article -
3
CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted thera... by Lars Fischer, Nicola Gökbuget, Stefan Schwartz, Thomas Burmeister, Harald Rieder, Monika Brüggemann, Dieter Hoelzer, Eckhard Thiel
Published 2009-02-01
Article -
4
Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia by Sebastian Koslowski, Rainer Glauben, Stefan Habringer, Thomas Burmeister, Ulrich Keller, Monika Brüggemann, Nicola Gökbuget, Stefan Schwartz
Published 2023-09-01
Article -
5
-
6
Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment by Thomas Burmeister, Daniela Gröger, Nicola Gökbuget, Bernd Spriewald, Michael Starck, Ahmet Elmaagacli, Dieter Hoelzer, Ulrich Keller, Stefan Schwartz
Published 2023-09-01
Article -
7
Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia by Benjamin Kobitzsch, Nicola Gökbuget, Stefan Schwartz, Richard Reinhardt, Monika Brüggemann, Andreas Viardot, Ralph Wäsch, Michael Starck, Eckhard Thiel, Dieter Hoelzer, Thomas Burmeister
Published 2017-10-01
Article -
8
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia by Claudia D. Baldus, Julia Thibaut, Nicola Goekbuget, Andrea Stroux, Cornelia Schlee, Max Mossner, Thomas Burmeister, Stefan Schwartz, Clara D. Bloomfield, Dieter Hoelzer, Eckhard Thiel, Wolf-Karsten Hofmann
Published 2009-10-01
Article -
9
STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria by Merle Sauer, Jörg Scheffel, Jörg Scheffel, Stefan Frischbutter, Stefan Frischbutter, Niklas Mahnke, Niklas Mahnke, Marcus Maurer, Marcus Maurer, Thomas Burmeister, Karoline Krause, Karoline Krause, Martin Metz, Martin Metz
Published 2022-07-01
Article -
10
Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia by Nicola Gökbuget, Gerhard Zugmaier, Matthias Klinger, Peter Kufer, Matthias Stelljes, Andreas Viardot, Heinz A. Horst, Svenja Neumann, Monika Brüggemann, Oliver G. Ottmann, Thomas Burmeister, Dorothea Wessiepe, Max S. Topp, Ralf Bargou
Published 2017-04-01
Article -
11
Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia by Thomas Burmeister, Stefan Schwartz, Almut Taubald, Edgar Jost, Thomas Lipp, Folker Schneller, Helmut Diedrich, Henrike Thomssen, Ulrich J.M. Mey, Jan Eucker, Harald Rieder, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel
Published 2007-12-01
Article -
12
Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia by Sandra Heesch, Nicola Goekbuget, Andrea Stroux, Jutta Ortiz Tanchez, Cornelia Schlee, Thomas Burmeister, Stefan Schwartz, Olga Blau, Ulrich Keilholz, Antonia Busse, Dieter Hoelzer, Eckhard Thiel, Wolf-Karsten Hofmann, Claudia D. Baldus
Published 2010-06-01
Article -
13
Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group by Thomas Burmeister, Gesine Bartels, Daniela Gröger, Heiko Trautmann, Stefan Schwartz, Klaus Lenz, Carola Tietze-Bürger, Andreas Viardot, Ralph Wäsch, Heinz-August Horst, Richard Reinhardt, Nicola Gökbuget, Dieter Hoelzer, Michael Kneba, Monika Brüggemann
Published 2014-02-01
Article -
14
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers by Laura E. Fischer, Laura E. Fischer, Sebastian Stintzing, Sebastian Stintzing, Volker Heinemann, Volker Heinemann, Volker Heinemann, Ulrich Keilholz, Ulrich Keilholz, Dietmar Keune, Claudia Vollbrecht, Thomas Burmeister, Thomas Burmeister, Andreas Kind, Lena Weiss, David Horst, David Horst, Thomas Kirchner, Thomas Kirchner, Thomas Kirchner, Frederick Klauschen, Frederick Klauschen, Frederick Klauschen, Frederick Klauschen, Andreas Jung, Andreas Jung, Andreas Jung, Christoph Benedikt Westphalen, Christoph Benedikt Westphalen, Christoph Benedikt Westphalen, Ivan Jelas, Ivan Jelas
Published 2022-05-01
Article -
15
Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies by John Jeongseok Yang, Tae Sung Park, Seung-Tae Lee, Ja-Young Seo, Seung Hwan Oh, Eun Hae Cho, Thomas Burmeister, Wolf-Dieter Ludwig, Claus Meyer, Rolf Marschalek, Hee-Jin Kim, Sun-Hee Kim
Published 2014-04-01
Article -
16
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy by Jana Ihlow, Sophia Gross, Leonie Busack, Anne Flörcken, Julia Jesse, Michaela Schwarz, Nina Rosa Neuendorff, Ann-Christin von Brünneck, Ioannis Anagnostopoulos, Seval Türkmen, Igor Wolfgang Blau, Thomas Burmeister, David Horst, Lars Bullinger, Jörg Westermann
Published 2021-11-01
Article -
17
FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling by Sven Liebig, Martin Neumann, Patricia Silva, Jutta Ortiz-Tanchez, Veronika Schulze, Konstandina Isaakidis, Cornelia Schlee, Michael P. Schroeder, Thomas Beder, Luc G. T. Morris, Timothy A. Chan, Lorenz Bastian, Thomas Burmeister, Stefan Schwartz, Nicola Gökbuget, Liliana H. Mochmann, Claudia D. Baldus
Published 2023-01-01
Article -
18
P355: FAVORABLE OUTCOME OF PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMATINIB, DOSE-REDUCED INDUCTION FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION –RESULTS FROM T... by Heike Pfeifer, Fabian Lang, Walter Fiedler, Matthias Stelljes, Folker Schneller, Björn Steffen, Boris Böll, Andreas Viardot, Christoph Faul, Lino Lars Teichmann, Hendrik Poeck, Jörg Westermann, Kerstin Schaefer-Eckart, Thomas Heinicke, Hubert Serve, Monika Brüggemann, Stefan Schwartz, Thomas Burmeister, Nicola Gökbuget
Published 2023-08-01
Article -
19
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy by Sophia Gross, Jana Ihlow, Leonie Busack, Kacper Adamiak, Jens Schrezenmeier, Julia Jesse, Michaela Schwarz, Anne Flörcken, Lam Giang Vuong, Kathrin Rieger, Jan Krönke, Philipp le Coutre, Vivien Boldt, Ann-Christin von Brünneck, David Horst, Thomas Burmeister, Igor-Wolfgang Blau, Ulrich Keller, Lars Bullinger, Jörg Westermann
Published 2024-09-01
Article -
20
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors. by Martin Neumann, Ebru Coskun, Lars Fransecky, Liliana H Mochmann, Isabelle Bartram, Nasrin Farhadi Sartangi, Sandra Heesch, Nicola Gökbuget, Stefan Schwartz, Christian Brandts, Cornelia Schlee, Rainer Haas, Ulrich Dührsen, Martin Griesshammer, Hartmut Döhner, Gerhard Ehninger, Thomas Burmeister, Olga Blau, Eckhard Thiel, Dieter Hoelzer, Wolf-Karsten Hofmann, Claudia D Baldus
Published 2013-01-01
Article